Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians
India contributes close to 20% of the global cervical cancer burden. This article reviews the preventive strategies against cervical cancer and suggest a few way forward for the prevention of cervical cancer in India. A literature review of online databases (Embase, Google Scholar, PubMed, Scopus) a...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-05-01
|
| Series: | Preventive Medicine: Research & Reviews |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/PMRR.PMRR_16_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849427951554134016 |
|---|---|
| author | Pooja Dwivedi Anita Upadhyay Lahariya Shalini Pandey Aswathy Sreedevi Ayush Lohiya Chandrakant Lahariya |
| author_facet | Pooja Dwivedi Anita Upadhyay Lahariya Shalini Pandey Aswathy Sreedevi Ayush Lohiya Chandrakant Lahariya |
| author_sort | Pooja Dwivedi |
| collection | DOAJ |
| description | India contributes close to 20% of the global cervical cancer burden. This article reviews the preventive strategies against cervical cancer and suggest a few way forward for the prevention of cervical cancer in India. A literature review of online databases (Embase, Google Scholar, PubMed, Scopus) and reports from government websites regarding cervical cancer and HPV vaccination in India was conducted. Currently, four different HPV vaccines are available in India: a bivalent vaccine, a nonavalent vaccine and two quadrivalent vaccines. To reduce India’s cervical cancer burden, the National Technical Advisory Group on Immunization (NTAGI) has advocated the widespread implementation of HPV vaccination. An indigenous HPV vaccine was given market authorisation by the Drugs Controller General of India (DCGI) in July 2022. There is a need to raise awareness regarding the benefits of HPV vaccines in India. The introduction of indigenous HPV vaccine might enhance the supply logistics and may increase the uptake of the vaccine. |
| format | Article |
| id | doaj-art-8ad8bac4476245998b63d8d75fdcedbb |
| institution | Kabale University |
| issn | 2950-5828 2950-5836 |
| language | English |
| publishDate | 2024-05-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Preventive Medicine: Research & Reviews |
| spelling | doaj-art-8ad8bac4476245998b63d8d75fdcedbb2025-08-20T03:28:51ZengWolters Kluwer Medknow PublicationsPreventive Medicine: Research & Reviews2950-58282950-58362024-05-011315716110.4103/PMRR.PMRR_16_23Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General PhysiciansPooja DwivediAnita Upadhyay LahariyaShalini PandeyAswathy SreedeviAyush LohiyaChandrakant LahariyaIndia contributes close to 20% of the global cervical cancer burden. This article reviews the preventive strategies against cervical cancer and suggest a few way forward for the prevention of cervical cancer in India. A literature review of online databases (Embase, Google Scholar, PubMed, Scopus) and reports from government websites regarding cervical cancer and HPV vaccination in India was conducted. Currently, four different HPV vaccines are available in India: a bivalent vaccine, a nonavalent vaccine and two quadrivalent vaccines. To reduce India’s cervical cancer burden, the National Technical Advisory Group on Immunization (NTAGI) has advocated the widespread implementation of HPV vaccination. An indigenous HPV vaccine was given market authorisation by the Drugs Controller General of India (DCGI) in July 2022. There is a need to raise awareness regarding the benefits of HPV vaccines in India. The introduction of indigenous HPV vaccine might enhance the supply logistics and may increase the uptake of the vaccine.https://journals.lww.com/10.4103/PMRR.PMRR_16_23cervavaccervical cancerhuman papillomavirusvaccinationindia |
| spellingShingle | Pooja Dwivedi Anita Upadhyay Lahariya Shalini Pandey Aswathy Sreedevi Ayush Lohiya Chandrakant Lahariya Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians Preventive Medicine: Research & Reviews cervavac cervical cancer human papillomavirus vaccination india |
| title | Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians |
| title_full | Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians |
| title_fullStr | Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians |
| title_full_unstemmed | Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians |
| title_short | Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians |
| title_sort | cervical cancer and human papilloma virus hpv vaccines a primer for general physicians |
| topic | cervavac cervical cancer human papillomavirus vaccination india |
| url | https://journals.lww.com/10.4103/PMRR.PMRR_16_23 |
| work_keys_str_mv | AT poojadwivedi cervicalcancerandhumanpapillomavirushpvvaccinesaprimerforgeneralphysicians AT anitaupadhyaylahariya cervicalcancerandhumanpapillomavirushpvvaccinesaprimerforgeneralphysicians AT shalinipandey cervicalcancerandhumanpapillomavirushpvvaccinesaprimerforgeneralphysicians AT aswathysreedevi cervicalcancerandhumanpapillomavirushpvvaccinesaprimerforgeneralphysicians AT ayushlohiya cervicalcancerandhumanpapillomavirushpvvaccinesaprimerforgeneralphysicians AT chandrakantlahariya cervicalcancerandhumanpapillomavirushpvvaccinesaprimerforgeneralphysicians |